PL3210990T3 - Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania - Google Patents

Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania

Info

Publication number
PL3210990T3
PL3210990T3 PL17166117T PL17166117T PL3210990T3 PL 3210990 T3 PL3210990 T3 PL 3210990T3 PL 17166117 T PL17166117 T PL 17166117T PL 17166117 T PL17166117 T PL 17166117T PL 3210990 T3 PL3210990 T3 PL 3210990T3
Authority
PL
Poland
Prior art keywords
preparations
preparation methods
levoisovalerylspiramycin iii
levoisovalerylspiramycin
iii
Prior art date
Application number
PL17166117T
Other languages
English (en)
Inventor
Yang Jiang
Xiaofeng Zhao
Original Assignee
Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shenyang Fuyang Pharmaceutical Technology Co., Ltd. filed Critical Shenyang Fuyang Pharmaceutical Technology Co., Ltd.
Publication of PL3210990T3 publication Critical patent/PL3210990T3/pl

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1025Acyltransferases (2.3)
    • C12N9/1029Acyltransferases (2.3) transferring groups other than amino-acyl groups (2.3.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00Preparation of compounds containing saccharide radicals
    • C12P19/44Preparation of O-glycosides, e.g. glucosides
    • C12P19/60Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin
    • C12P19/62Preparation of O-glycosides, e.g. glucosides having an oxygen of the saccharide radical directly bound to a non-saccharide heterocyclic ring or a condensed ring system containing a non-saccharide heterocyclic ring, e.g. coumermycin, novobiocin the hetero ring having eight or more ring members and only oxygen as ring hetero atoms, e.g. erythromycin, spiramycin, nystatin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
PL17166117T 2010-05-25 2011-05-25 Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania PL3210990T3 (pl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
CN201010182108 2010-05-25
CN201010182109 2010-05-25
CN201010182111 2010-05-25
PCT/CN2011/074644 WO2011147313A1 (zh) 2010-05-25 2011-05-25 左旋异戊酰螺旋霉素i、ii或iii,及其制剂、制备方法及应用
EP17166117.6A EP3210990B1 (en) 2010-05-25 2011-05-25 Levoisovalerylspiramycin iii and preparations, preparation methods and uses thereof
EP11786085.8A EP2578595B1 (en) 2010-05-25 2011-05-25 Crystalline levoisovalerylspiramycin i

Publications (1)

Publication Number Publication Date
PL3210990T3 true PL3210990T3 (pl) 2020-10-05

Family

ID=45003321

Family Applications (3)

Application Number Title Priority Date Filing Date
PL17166118T PL3210991T3 (pl) 2010-05-25 2011-05-25 Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie
PL17166117T PL3210990T3 (pl) 2010-05-25 2011-05-25 Lewoizowalerylospiramycyna III i jej preparaty, sposoby wytwarzania i zastosowania
PL11786085T PL2578595T3 (pl) 2010-05-25 2011-05-25 Krystaliczna lewoizowalerylospiramycyna I

Family Applications Before (1)

Application Number Title Priority Date Filing Date
PL17166118T PL3210991T3 (pl) 2010-05-25 2011-05-25 Postać krystaliczna lewoizowalerylospiramycyny II oraz preparaty, sposoby wytwarzania i ich zastosowanie

Family Applications After (1)

Application Number Title Priority Date Filing Date
PL11786085T PL2578595T3 (pl) 2010-05-25 2011-05-25 Krystaliczna lewoizowalerylospiramycyna I

Country Status (15)

Country Link
US (1) US8778896B2 (pl)
EP (3) EP2578595B1 (pl)
JP (1) JP5945868B2 (pl)
KR (2) KR101706518B1 (pl)
BR (1) BR112012029913B1 (pl)
CA (3) CA2915222C (pl)
DK (3) DK2578595T3 (pl)
ES (3) ES2633723T3 (pl)
MX (1) MX340626B (pl)
MY (1) MY164231A (pl)
PL (3) PL3210991T3 (pl)
PT (1) PT3210990T (pl)
RU (3) RU2647236C1 (pl)
WO (1) WO2011147313A1 (pl)
ZA (3) ZA201209738B (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112012029905B1 (pt) * 2010-05-25 2022-01-11 Shenyang Fuyang Pharmaceutical Technology Co., Ltd Levocarrimicina, composições farmacêutica, métodos de preparação e uso dos mesmos
CN105497053B (zh) * 2015-12-31 2018-02-13 沈阳福洋医药科技有限公司 可利霉素在抗结核分枝杆菌感染中的应用
CA3068921A1 (en) * 2017-07-04 2019-01-10 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. Use of isovaleryl spiramycin i, ii and/or iii in manufacturing medicament for treating and/or preventing tumor and medicament
EP3741374A4 (en) * 2018-01-19 2021-04-07 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. MTOR-INHIBITOR, PHARMACEUTICAL COMPOSITION AND ITS USES
RU2771046C2 (ru) * 2018-01-19 2022-04-25 Шенянг Фуянг Фармасьютекал Технолоджи Ко., Лтд. Применение карримицина или его активных ингредиентов
CN110384710B (zh) * 2018-04-17 2023-01-10 沈阳福洋医药科技有限公司 一种用于预防和/或治疗疼痛的药物、组合产品及其应用
EP3782627A4 (en) * 2018-04-17 2021-07-07 Shanghai Tonglian Pharmaceutical Co., Ltd. MEDICINAL PRODUCT USED TO PREVENT AND / OR TREAT PAIN AND / OR FEVER, A COMBINATION PRODUCT, AND USE OF THEM
EP3970728A4 (en) * 2019-05-16 2022-07-27 Shenyang Fuyang Pharmaceutical Technology Co., Ltd. MEDICINE AND COMBINATION PRODUCT USED FOR THE PREVENTION, RELIEF AND/OR TREATMENT OF FIBROSIS AND USE OF IT
CN112239483B (zh) * 2019-07-18 2023-10-27 沈阳福洋医药科技有限公司 一种化合物及药物组合物
US11351185B2 (en) 2020-03-11 2022-06-07 Asclea Corporation Use of isovalerylspiramycins as anti-cancer agents to inhibit metastasis

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5334788A (en) * 1976-09-11 1978-03-31 Sanraku Inc Antibiotics spiramycin derivatives
CN1058295C (zh) 1997-06-03 2000-11-08 中国医学科学院医药生物技术研究所 一种利用基因工程技术制造生技霉素的方法
CN1169947C (zh) * 2002-11-19 2004-10-06 中国医学科学院医药生物技术研究所 必特螺旋霉素的基因工程菌株螺旋霉素链霉菌wsj-195
CN1237976C (zh) * 2003-12-23 2006-01-25 沈阳同联集团有限公司 必特螺旋霉素及其在抗感染性疾病中的应用
AU2005273592A1 (en) * 2004-08-12 2006-02-23 Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. Use of cell-specific conjugates for treatment of inflammatory diseases of the gastrointestinal tract
CN101054553A (zh) * 2007-04-09 2007-10-17 中国医学科学院医药生物技术研究所 异戊酰螺旋霉素i基因工程菌株的构建
CN101649325B (zh) * 2009-07-03 2011-09-07 中国医学科学院医药生物技术研究所 一种提高基因工程异戊酰螺旋霉素主组分含量的基因串连技术
CN101785778A (zh) 2010-03-09 2010-07-28 沈阳同联集团有限公司 异戊酰螺旋霉素i的分离制备及其应用
CN101785779B (zh) 2010-03-09 2014-03-05 沈阳同联集团有限公司 异戊酰螺旋霉素ii的分离制备
CN101773510B (zh) * 2010-03-09 2013-06-05 沈阳同联集团有限公司 异戊酰螺旋霉素iii的分离制备
BR112012029905B1 (pt) * 2010-05-25 2022-01-11 Shenyang Fuyang Pharmaceutical Technology Co., Ltd Levocarrimicina, composições farmacêutica, métodos de preparação e uso dos mesmos

Also Published As

Publication number Publication date
CA2800021A1 (en) 2011-12-01
PL3210991T3 (pl) 2020-03-31
MX340626B (es) 2016-07-18
US20130065848A1 (en) 2013-03-14
JP2013528166A (ja) 2013-07-08
DK3210990T3 (da) 2020-03-23
CA2915222C (en) 2019-03-12
DK3210991T3 (da) 2019-11-11
ZA201406382B (en) 2015-12-23
MY164231A (en) 2017-11-30
BR112012029913A8 (pt) 2018-01-09
KR20160017124A (ko) 2016-02-15
EP2578595A4 (en) 2013-11-06
CA2915236A1 (en) 2011-12-01
CA2800021C (en) 2016-03-22
DK2578595T3 (en) 2017-07-10
EP3210991B1 (en) 2019-08-07
PT3210990T (pt) 2020-04-01
EP2578595A1 (en) 2013-04-10
CA2915236C (en) 2019-03-12
EP3210991A1 (en) 2017-08-30
US8778896B2 (en) 2014-07-15
EP2578595B1 (en) 2017-04-19
EP3210990A1 (en) 2017-08-30
JP5945868B2 (ja) 2016-07-13
BR112012029913B1 (pt) 2021-02-02
ES2633723T3 (es) 2017-09-25
CA2915222A1 (en) 2011-12-01
ES2754614T3 (es) 2020-04-20
ES2781425T3 (es) 2020-09-02
BR112012029913A2 (pt) 2017-11-28
PL2578595T3 (pl) 2017-10-31
MX2012013470A (es) 2013-03-18
ZA201406381B (en) 2016-08-31
RU2012156420A (ru) 2014-06-27
RU2647236C1 (ru) 2018-03-14
KR20130041829A (ko) 2013-04-25
WO2011147313A1 (zh) 2011-12-01
EP3210990B1 (en) 2020-01-01
ZA201209738B (en) 2015-04-29
KR101706518B1 (ko) 2017-02-14
RU2593498C2 (ru) 2016-08-10
RU2647237C1 (ru) 2018-03-14

Similar Documents

Publication Publication Date Title
EP2624845A4 (en) REINFORCED MSC PREPARATIONS
EP2542221A4 (en) CONCENTRATED PROTEIN FORMULATIONS AND USES THEREOF
PL2547692T3 (pl) Pochodne peptydów, ich wytwarzanie i ich zastosowania
ZA201209739B (en) Levocarrimycin,pharmaceutical compositions,preparation methods and uses thereof
EP2530079A4 (en) PHENYL-C-GLUCOSIDE DERIVATIVES, PREPARATION METHODS AND USES THEREOF
ZA201406382B (en) Levoisovalerylspiramycin i,ii,iii and preparations ,preparation methods and uses thereof
ZA201208541B (en) Antibody preparations
EP2529227A4 (en) IMMUNOGENIC PREPARATIONS BASED ON CYTOMEGALOVIRUS
EP2657188A4 (en) FLUOROGRAPHIC AND METHOD FOR PREPARING THE SAME
EP2796442A4 (en) ANALOG COMPOUND FROM A CAJANINE STRUCTURE, MANUFACTURING METHOD AND USE THEREOF
EP2550954A4 (en) VASELINE-TYPE COMPOSITION AND COSMETIC PREPARATION
EP2573072A4 (en) INDENOQUINOLONE COMPOUND, PROCESS FOR PREPARING THE SAME, AND USE THEREOF
EP2615100A4 (en) FRUCTOSYL-PUERARIN, PROCESS FOR PREPARING THE SAME AND APPLICATIONS THEREOF
EP2594281A4 (en) INSULIN LIPID COMPLEX, MANUFACTURING METHOD AND PREPARATION THEREFROM
IL225990A0 (en) Electrophilic reagents for monomethylation, their preparation and uses
EP2581371A4 (en) PYRROLYL-SUBSTITUTED DIHYDROINDOL-2-ON DERIVATIVES, METHOD FOR THE PRODUCTION THEREOF AND USES THEREOF
EP2671878A4 (en) SUBSTITUTED N-PENTANAMIDE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
EP2546226A4 (en) 1-METHOXYL-2,6,10-TRIMETHYL-1,3,5,9-UNDEC-TETRAENE, PREPARATION METHOD THEREOF AND USES THEREOF
EP2530084A4 (en) COPOLYMER WITH FLUORENYLPORPHYRIN-ANTHRACENE PATTERN, PREPARATION METHOD AND USE THEREOF
EP2551259A4 (en) SITAGLIPTIN INTERMEDIATE COMPOUNDS, PREPARATION METHODS AND USES THEREOF
EP2766183A4 (en) IRON FIBER COMPOSITION, PREPARATION THEREOF AND USES THEREOF
EP2752419A4 (en) SPIROBENZYLAMINE-PHOSPHINE, ITS PREPARATION METHOD AND USE
EP2515903A4 (en) COMPOUNDS, PREPARATION AND USES THEREOF
EP2551271A4 (en) COPOLYMER WITH FLUORENYLPORPHYRINE BENZOLE, PREPARATION METHOD AND USE
IL226108A0 (en) Highly efficient catalysts, their preparation and use